Financials
- Financial year
- 2025
- Total assets
- €3.9m
- Loss
- -€15.7m
- Solvency
- -406.7%
Total assets▼ 73.4%
Net result
20182025
Precirix
Dissolution or liquidationOverview
Activity
Research and development on biotechnology
NACE 72101Other research and development on natural sciences NACE 72109
1 site
Size
€3.9mtotal assets 2025
- Staff
- 20.6 FTE
- Equity
- -€15.7m
- Loss
- -€15.7m
Turnover not published (abbreviated format)
Financial health
Dissolution or liquidation: no score
Structure
- Board
- 4 members
- Pharmetis SàrlManaging director · permanent representative Plitz Thomas
Auditor: BDO
Signalsraises riskRegister: dissolution or liquidationNegative equityneutralLatest accounts filed on timeShow the evidence
Signals
Three signals.
raises riskneutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year -€15.7m
neutral · Latest accounts filed on time
The financial year that closed on 17-12-2025 was due by 17-07-2026 and was filed on 12-05-2026, 66 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
66 days early
2024
21 days early
2023
69 days early
2022
67 days early
2021
67 days early
2020
60 days early
2019
72 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 60 days before the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 33% of those companies filed late.
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · abbreviated…
- Resignations & appointments · End &…Resignations: Cetium AS, Mesonax Ltd…
- Annual accounts filedfinancial year 2024 · abbreviated…
Key points
By topic
Board & ownership
- Board
- 4 members
- Auditor
- BDO
- BOS Jasper MarnixDirector
- BOTTI SimoneDirector
- MOUMDJIAN (geh. DANDIGUIAN) Sabine KoharDirector
- Pharmetis SàrlManaging director
Network & group
- Connected companies
- 3
Timeline
- Events
- 39
- Since
- 2014
- 15-05-2025Amendment of the articles
- 06-03-2025Resignation: Sabine Dandiguian (board director)
- 28-11-2024Miscellaneous
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Research and development on biotechnologyNACE 72101
- Founded
- 15-10-2014
- Year ends
- 17-12
- Peppol
- Still in the Peppol directory
Articles of association
- Provisions read
- 12
- Annual meeting
- Second Friday of May at 16:00
- Purpose
- “Alle activiteiten die verband houden met fundamenteel of toegepast onderzoek alsook de…” (deed in Dutch)
Go further with this company
What became of the directors' other companies?Supplier due diligence Who ran this company, and where was it based, on a given date before it ended?Company as of a date How is this company connected to another party?Network investigator How is the research and development on biotechnology sector doing?Sector figures
Investigating this company? Keep it with today's facts in a case file.